Food and Drug Administration (FDA)
Quick facts
Marketed products
- omeprazole/sodium bicarbonate · Gastroenterology
Omeprazole inhibits gastric acid secretion by blocking the proton pump in stomach parietal cells, while sodium bicarbonate provides rapid acid neutralization.
Phase 1 pipeline
- Dofetilide and Diltiazem
- Escitalopram and Oxycodone
- Moxifloxacin and Cobicistat
- Oxycodone and Midazolam
- Oxycodone, Paroxetine, and Quetiapine
- Paroxetine and Oxycodone
- Part 1: Lotion
- Part 1: Spray 1
- Part 1: Spray 2
- Part 2: Aerosol Spray
- Part 2: Nonaerosol Spray
- Part 2: Pump Spray
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Food and Drug Administration (FDA) portfolio CI brief
- Food and Drug Administration (FDA) pipeline updates RSS
Frequently asked questions about Food and Drug Administration (FDA)
What are Food and Drug Administration (FDA)'s marketed drugs?
Top marketed products include omeprazole/sodium bicarbonate.
Related
- omeprazole/sodium bicarbonate · Gastroenterology
- Sector hub: All tracked pharma companies